Ryan B. Rountree

2.1k citations

28 papers · 1.5k indexed · h-index 15

Co-authors: David M. Kingsley Stephen H. Settle Kay M. Higgins Abhishek Sinha Michael SchoorHao ChenVincent R. Harley Melissa E. Marks
Topics: Immunotherapy and Immune Responses (9 papers)Cancer Immunotherapy and Biomarkers (8 papers)CAR-T cell therapy research (7 papers)
Cited by: Rheumatology Orthopedics and Sports Medicine Immunology and Allergy
Journals: Journal of Clinical Oncology Blood PLoS ONE
Partner nations: United States Germany Japan

In The Last Decade

Ryan B. Rountree

25 papers receiving 1.5k citations

Peers

Countries citing papers authored by Ryan B. Rountree

Since Specialization

Citations

This map shows the geographic impact of Ryan B. Rountree's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan B. Rountree with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan B. Rountree more than expected).

Fields of papers citing papers by Ryan B. Rountree

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan B. Rountree. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan B. Rountree. The network helps show where Ryan B. Rountree may publish in the future.

Co-authorship network of co-authors of Ryan B. Rountree

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan B. Rountree. A scholar is included among the top collaborators of Ryan B. Rountree based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan B. Rountree. Ryan B. Rountree is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	BTK Degradation As a Novel Therapeutic Strategy in Relapsed CNS Lymphoma: Proof of Concept Studies in Intracranial Patient-Derived, Rodent Models 2024 ·Blood ·Jun Ma,Michael P. Randall,Ming‐Chi Lu,Lingjing Chen,Huimin Geng,(unknown),(unknown),Mark Noviski,Ryan B. Rountree,James L. Rubenstein	1
2	Abstract 3423: NX-2127: A first-in-class clinical stage degrader of BTK and IKZF1/3 for the treatment of patients with B cell malignancies 2023 ·Cancer Research ·(unknown),(unknown),Brandon Bravo,(unknown),(unknown),(unknown),Jun Ma,Joel McIntosh,(unknown),(unknown),Mark Noviski,(unknown),(unknown),Ryan B. Rountree,(unknown),(unknown),Jordan Ye,Stephanie Yung	4
3	OTHR-02. CHIMERIC AURORA A KINASE (AURKA) DEGRADERS EFFICIENTLY TARGET N-MYC 2023 ·Neuro-Oncology ·(unknown),(unknown),(unknown),(unknown),(unknown),Bikash Adhikari,Cristiana Guiducci,Ryan B. Rountree,Christoph Grohmann,(unknown),Ya‐Wen Lu,(unknown),(unknown),(unknown),Gwenn M. Hansen,John M. Maris,Yaël P. Mossé,Martin Eilers,Elmar Wolf,Martine F. Roussel	0
4	Abstract 573: Ex-vivo inhibition of CBL-B with a novel small molecule inhibitor, NX-0255, enhances persistence and anti-tumor activity of adoptively transferred CD8+ T cells in mouse tumor models 2022 ·Cancer Research ·Marilena Gallotta,(unknown),Alexandra Borodovsky,(unknown),Jennifer A. Stokes,Jennifa Gosling,Gwenn M. Hansen,Arthur Sands,Ryan B. Rountree,Cristiana Guiducci	1
5	331 A novel small molecule inhibitor of CBL-B shows potent antitumor activity in combination with Pmel-1 adoptive cell transfer in an aggressive mouse melanoma model 2022 ·Regular and Young Investigator Award Abstracts ·(unknown),(unknown),Serena Ranucci,(unknown),Frederick Cohen,Gwenn M. Hansen,Arthur Sands,Ryan B. Rountree,Cristiana Guiducci	1
6	Nx-5948, a Selective Degrader of BTK with Activity in Preclinical Models of Hematologic and Brain Malignancies 2021 ·Blood ·Daniel Robbins,Mark Noviski,Ryan B. Rountree,(unknown),(unknown),(unknown),Dane E. Karr,Aileen Kelly,(unknown),Jun Ma,(unknown),(unknown),(unknown),Cristiana Guiducci,Gwenn M. Hansen,Arthur Sands	35
7	Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cells 2016 ·Cancer Immunology Immunotherapy ·Susan P. Foy,Stefanie Mandl,(unknown),(unknown),(unknown),(unknown),Alain Delcayre,James B. Breitmeyer,Alex Franzusoff,Ryan B. Rountree	26
8	Poxvirus-Based Active Immunotherapy with PD-1 and LAG-3 Dual Immune Checkpoint Inhibition Overcomes Compensatory Immune Regulation, Yielding Complete Tumor Regression in Mice 2016 ·PLoS ONE ·Susan P. Foy,Barbara Sennino,(unknown),(unknown),(unknown),(unknown),(unknown),Alex Franzusoff,Ryan B. Rountree,Stefanie Mandl	29
9	Elucidating immunologic mechanisms of PROSTVAC cancer immunotherapy 2014 ·Journal for ImmunoTherapy of Cancer ·Stefanie Mandl,Ryan B. Rountree,(unknown),Susan P. Foy,(unknown),(unknown),(unknown),Alain Delcayre,Alex Franzusoff	15
10	The role of Irf6 in tooth epithelial invagination 2012 ·Developmental Biology ·James Blackburn,Atsushi Ohazama,Katsushige Kawasaki,(unknown),Bigang Liu,Kenya Honda,Ryan B. Rountree,Yinling Hu,Maiko Kawasaki,Walter Birchmeier,Ruth Schmidt‐Ullrich,Akira Kinoshita,Brian C. Schutte,Nigel L. Hammond,Michael J. Dixon,Paul T. Sharpe	16
11	Exosome Targeting of Tumor Antigens Expressed by Cancer Vaccines Can Improve Antigen Immunogenicity and Therapeutic Efficacy 2011 ·Cancer Research ·Ryan B. Rountree,Stefanie Mandl,(unknown),(unknown),(unknown),(unknown),(unknown),Kay Brinkmann,Ulrike Dirmeier,Reiner Laus,Alain Delcayre	130
12	Immunotherapy with MVA-BN®-HER2 induces HER-2-specific Th1 immunity and alters the intratumoral balance of effector and regulatory T cells 2011 ·Cancer Immunology Immunotherapy ·Stefanie Mandl,Ryan B. Rountree,(unknown),(unknown),(unknown),(unknown),Ulrike Dirmeier,Robin Steigerwald,Thierry Giffon,Reiner Laus,Alain Delcayre	22
13	Muscle Contraction Is Necessary to Maintain Joint Progenitor Cell Fate 2009 ·Developmental Cell ·Joy Kahn,Yulia Shwartz,Einat Blitz,Sharon Krief,Amnon Sharir,Dario Breitel,Révital Rattenbach,Frédéric Relaix,Pascal Maire,Ryan B. Rountree,David M. Kingsley,Elazar Zelzer	191
14	RIP4 Regulates Epidermal Differentiation and Cutaneous Inflammation 2009 ·Journal of Investigative Dermatology ·Ryan B. Rountree,Cynthia R. Willis,Huyen Dinh,Hal Blumberg,Keith Bailey,Charles R. Dean,Jacques J. Peschon,Pamela M. Holland	41
15	A distinct cohort of progenitor cells participates in synovial joint and articular cartilage formation during mouse limb skeletogenesis 2008 ·Developmental Biology ·Eiki Koyama,Yoshihiro Shibukawa,Motohiko Nagayama,Hiroki Sugito,Blanche Young,Takahito Yuasa,Takahiro Okabe,Takanaga Ochiai,(unknown),Ryan B. Rountree,David M. Kingsley,Masahiro Iwamoto,Motomi Enomoto‐Iwamoto,Maurizio Pacifici	263
16	Synovial Joint Formation during Mouse Limb Skeletogenesis 2007 ·Annals of the New York Academy of Sciences ·Eiki Koyama,Takanaga Ochiai,Ryan B. Rountree,David M. Kingsley,Motomi Enomoto‐Iwamoto,Masahiro Iwamoto,Maurizio Pacifici	55
17	Mineral Formation in Joints Caused by Complete or Joint-Specific Loss of ANK Function 2006 ·Journal of Bone and Mineral Research ·Kyle A. Gurley,Hao Chen,Catherine Guenther,Elizabeth T. Nguyen,Ryan B. Rountree,Michael Schoor,David M. Kingsley	59
18	BMP Receptor Signaling Is Required for Postnatal Maintenance of Articular Cartilage 2004 ·PLoS Biology ·Ryan B. Rountree,Michael Schoor,Hao Chen,Melissa E. Marks,Vincent R. Harley,Yuji Mishina,David M. Kingsley	227
19	Multiple joint and skeletal patterning defects caused by single and double mutations in the mouse Gdf6 and Gdf5 genes 2003 ·Developmental Biology ·Stephen H. Settle,Ryan B. Rountree,Abhishek Sinha,(unknown),Kay M. Higgins,David M. Kingsley	283
20	A Large-Scale in Situ Screen Provides Molecular Evidence for the Induction of Eye Anterior Segment Structures by the Developing Lens 2001 ·Developmental Biology ·Catherine J. Thut,Ryan B. Rountree,(unknown),David M. Kingsley	101

About Ryan B. Rountree

Ryan B. Rountree is a scholar working on Immunology, Genetics and Developmental Biology, having authored 28 papers that have together received 1.5k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (9 papers), Cancer Immunotherapy and Biomarkers (8 papers) and CAR-T cell therapy research (7 papers). The work is most often cited by research in Rheumatology (506 citations), Orthopedics and Sports Medicine (142 citations) and Immunology and Allergy (98 citations). Ryan B. Rountree has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include David M. Kingsley, Stephen H. Settle, Kay M. Higgins, Abhishek Sinha, Michael Schoor, Hao Chen, Vincent R. Harley, Melissa E. Marks, Yuji Mishina and Masahiro Iwamoto. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact